Overall rank by patents
#24,864
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 13 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
NMC holds 11 US patents across 13 technology areas, rank #24,864 of 50,000 tracked assignees.
NMC, Inc. has been granted 11 US utility patents between 2015 and 2022, placing NMC, Inc. at rank #24,864 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.7 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, NMC, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, NMC sits between Nippon A&L Inc. (11 patents, rank #24,860) and Novatrans Group Sa (11 patents, rank #24,868) - the closest US assignees by grant volume. The composite Innovation Score of 29.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 6 in the 2015–2019 window, a -17% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. NMC, Inc.'s 10.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark NMC, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NIPPON A&L INC.
11 patents
NIPPON MEDICAL SCHOOL FOUNDATION
11 patents
NIPPON YUSEN KABUSHIKI KAISHA
11 patents
NITTO PHARMACEUTICAL INDUSTRIES, LTD.
11 patents
NORAMCO, LLC
11 patents
NORTHSTAR BATTERY COMPANY, LLC
11 patents
NOVASIGHT LTD.
11 patents
NOVATRANS GROUP SA
11 patents
NMC, INC.
11 patents
What this shows NMC holds 11 patents at rank #24,864, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
NMC's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 70% higher than 30% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 9.1% |
| 2016 | 3 | 27.3% |
| 2018 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 2 | 18.2% |
| 2022 | 1 | 9.1% |
Top 13 of 13 technology areas
Overall rank by patents
#24,864
Across all tracked assignees
29.1 out of 100
How to use this portfolio
NMC's 11 grants land it in the top 70% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.